Elisabeth Gillespie

713 total citations
10 papers, 137 citations indexed

About

Elisabeth Gillespie is a scholar working on Hematology, Molecular Biology and Epidemiology. According to data from OpenAlex, Elisabeth Gillespie has authored 10 papers receiving a total of 137 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 4 papers in Molecular Biology and 3 papers in Epidemiology. Recurrent topics in Elisabeth Gillespie's work include Blood groups and transfusion (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Erythrocyte Function and Pathophysiology (2 papers). Elisabeth Gillespie is often cited by papers focused on Blood groups and transfusion (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Erythrocyte Function and Pathophysiology (2 papers). Elisabeth Gillespie collaborates with scholars based in United States, United Kingdom and Malaysia. Elisabeth Gillespie's co-authors include E. R. Gold, G. H. Tovey, Hannah B Lewis, William J. Weiner, Deanne Taylor, David B. Weiner, Martin Carroll, Albert J. Sylvester, Jean Boyer and Yoseph Barash and has published in prestigious journals such as The Lancet, Nucleic Acids Research and Journal of Clinical Oncology.

In The Last Decade

Elisabeth Gillespie

10 papers receiving 133 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elisabeth Gillespie United States	7	59	38	32	25	24	10	137
Elizabeth Cramer France	5	83 1.4×	64 1.7×	23 0.7×	11 0.4×	23 1.0×	6	203
Giorgia Saporiti Italy	8	41 0.7×	55 1.4×	51 1.6×	40 1.6×	26 1.1×	18	177
G. Brittinger Germany	7	67 1.1×	75 2.0×	21 0.7×	6 0.2×	38 1.6×	10	151
Agnieszka Tomaszewska Poland	8	35 0.6×	76 2.0×	53 1.7×	21 0.8×	38 1.6×	27	194
Samantha Nichele Brazil	6	52 0.9×	89 2.3×	38 1.2×	17 0.7×	41 1.7×	14	152
Bella Shadur Australia	10	65 1.1×	57 1.5×	97 3.0×	35 1.4×	39 1.6×	20	214
Elena Campos‐Sánchez Spain	8	82 1.4×	18 0.5×	43 1.3×	13 0.5×	32 1.3×	10	155
K. J. De Knop Belgium	10	37 0.6×	20 0.5×	73 2.3×	7 0.3×	17 0.7×	12	428
Yuki Kagiyama Japan	7	126 2.1×	70 1.8×	66 2.1×	7 0.3×	15 0.6×	10	202
Alessandro Farris Italy	5	28 0.5×	20 0.5×	12 0.4×	32 1.3×	61 2.5×	6	129

Countries citing papers authored by Elisabeth Gillespie

Since Specialization

Citations

This map shows the geographic impact of Elisabeth Gillespie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Gillespie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Gillespie more than expected).

Fields of papers citing papers by Elisabeth Gillespie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Gillespie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Gillespie. The network helps show where Elisabeth Gillespie may publish in the future.

Co-authorship network of co-authors of Elisabeth Gillespie

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Gillespie. A scholar is included among the top collaborators of Elisabeth Gillespie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Gillespie. Elisabeth Gillespie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Amin, Milan R., Peter C. Belafsky, Simon R. Best, et al.. (2025). DNA Immunotherapy ( INO ‐3107) Results in Long‐Term Surgery Reduction in RRP. The Laryngoscope. 135(11). 4287–4295. 1 indexed citations

Jacobson, Jeffrey M., David M. Zahrieh, Carrie Strand, et al.. (2022). Phase I Trial of a Therapeutic DNA Vaccine for Preventing Hepatocellular Carcinoma from Chronic Hepatitis C Virus (HCV) Infection. Cancer Prevention Research. 16(3). 163–173. 11 indexed citations

Reardon, David A., Steven Brem, Arati Desai, et al.. (2022). Intramuscular (IM) INO-5401 + INO-9012 with electroporation (EP) in combination with cemiplimab (REGN2810) in newly diagnosed glioblastoma.. Journal of Clinical Oncology. 40(16_suppl). 2004–2004. 19 indexed citations

Aggarwal, Charu, Roger B. Cohen, Matthew P. Morrow, et al.. (2020). Immune Therapy Targeting E6/E7 Oncogenes of Human Papillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory Papillomatosis. Vaccines. 8(1). 56–56. 20 indexed citations

Black, Kathryn L., Ammar S. Naqvi, Mukta Asnani, et al.. (2018). Aberrant splicing in B-cell acute lymphoblastic leukemia. Nucleic Acids Research. 46(2). 1043–1043. 37 indexed citations

Gold, E. R., et al.. (1961). Build‐up with Antigen Absorption Test. Vox Sanguinis. 6(2). 142–150. 2 indexed citations

Gold, E. R., Elisabeth Gillespie, & G. H. Tovey. (1961). A Serum Containing 8 Antibodies. Vox Sanguinis. 6(2). 157–163. 2 indexed citations

Gillespie, Elisabeth & E. R. Gold. (1960). Weakening of the B‐ Antigen by the Presence of A₁ as Shown by Reactions with Fomes Fomentarius (Anti‐B) Extract. Vox Sanguinis. 5(5). 497–502. 14 indexed citations

Gillespie, Elisabeth, et al.. (1959). CORD-BLOOD FINDINGS IN ABO HÆMOLYTIC DISEASE. The Lancet. 273(7078). 860–863. 10 indexed citations

10.

Weiner, William J., et al.. (1956). “Albumin” Auto‐Agglutinating Property in Three Sera. “A Pitfall for the Unwary”. Vox Sanguinis. 1(4). 279–288. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact